Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma

Journal of Clinical Apheresis

Volumn 14, Issue 1, 1999, Pages 31-34

  Zimmerman, Todd M ^a,d   Michelson, Glenn C ^b   Mick, Rosemarie ^c   Grinblatt, David L ^a   Williams, Stephanie F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d SECTION OF HEMATOLOGY ONCOLOGY   (United States)

Author keywords

Mobilization; Peripheral blood progenitors; Transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE MARROW RESCUE; CLINICAL ARTICLE; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PRACTICE GUIDELINE; THROMBOCYTE COUNT;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EVALUATION STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HODGKIN DISEASE; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0032941821     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1999)14:1<31::AID-JCA6>3.0.CO;2-C     Document Type: Article

References (16)

1. Philip R, Guglielmi C, Hagenbeek A, Somers R, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995;333:1540-1545.
2. Burns LJ, Daniels KA, McGlave PB, et al. Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival. Bone Marrow Transplant 1995;16:13-18.
3. Zimmerman TM, Mick R, Myers S, Lee WJ, Bender JG, Williams SF. Source of stem cells impacts upon hematopoietic recovery after high-dose chemotherapy. Bone Marrow Transplanation 1995;15:923-927.
4. Sheridan WP, Begley CG, Juttner CA, et al. Effect of peripheral blood progenitor progenitors mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1993;339: 640-644.
5. Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplantation 1995;15:439-444.
6. Bender JG, To LB, Williams SF, et al. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-341.
7. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-2555.
8. Brandwein JM, Callum J, Sutcliffe SB, et al. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1990;6: 291-294.
9. Debecker A, Henon P, Leper M, et al. Collection de cellules souches circulante en sortie d'aplasie post-chimiotherapique dans les leudemies aigues. Nouv Rev Fr Hematol 1986;28:287-292.
10. Tilly H, Bastit D, Lucet JC, et al. Haemopoietic reconstitution after autologous peripheral blood stem cell transplanation in acute leukemia. Lancet 1986;ii:154-155.
11. + peripheral blood stem cell (PBSC) dose influences engraftment kinetics and other relevant clinical variable (Abstract 956). Proc ASCO 1996;15:333.
12. + cells by flow cytometry: Application to the harvesting and transplantation of peripheral blood stem cells. In: Wunder E, Sovalat H, Henon P, et al., editors. Hematopoietic stem cells: the mulhouse manual. AlphaMed Press: Dayton; 1994. p 31-43.
13. Kessinger A, Anderson J, Bishop J, et al. Lymphoma patients who require platelet transfusions during blood stem cell collection have slower platelet recovery after high-dose therapy and autotransplant (Abstract 397). Blood 1995;86:103a.
14. Ho AD, Gluck S, Germond D, et al. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1994;8: 1738-1746.
15. Elliot C, Samson DM, Armitage MP, et al. When to harvest peripheral blood stem cells after mobilization chemotherapy: prediction of CD34-positive cell yielded by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996;14: 970-973.
16. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-515.